Mai-Britt Zocca - Mar 20, 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
Stock symbol
IOBT
Transactions as of
Mar 20, 2023
Transactions value $
$0
Form type
4
Date filed
3/22/2023, 04:34 PM
Previous filing
Nov 12, 2021
Next filing
Aug 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +500K $0.00 500K Mar 20, 2023 Common Stock 500K $1.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.